Możliwości zastosowania terapii fotodynamicznej w leczeniu chorób naczyń krwionośnych

Derkacz, A.; Biały, D.; Wawrzyńska, M.

Artykuł - szczegóły

Tytuł artykułu

Możliwości zastosowania terapii fotodynamicznej w leczeniu chorób naczyń krwionośnych

Autorzy

Derkacz A. , Biały D. , Wawrzyńska M.

Wybrane pełne teksty z tego czasopisma

http://www.inzynieria-biomedyczna.com/

Identyfikatory

Warianty tytułu

A potential role for photodynamic therapy in cardiovascular medicine

Języki publikacji

Abstrakty

Terapia fotodynamiczna (PDT) jest nową, obiecującą metodą wprowadzaną do leczenia chorób naczyń krwionośnych. Zastosowanie PDT daje możliwość bezpiecznego i selektywnego zniszczenia struktur blaszki miażdżycowej oraz powstrzymania ewentualnego procesu nawrotu zwężenia po zabiegach konwencjonalnej angioplastyki wewnątrznaczyniowej. W poniższym opracowaniu przedstawiono wyniki przeprowadzonych do tej pory doświadczeń na eksperymentalnych modelach zwierzęcych oraz pierwszych prób klinicznych z zastosowaniem PDT.

Photodynamic therapy (PDT) is a new promising method applied to cardiovascular diseases. The potential of PDT for atraumatic and effective debulking of atheromatous plaque and postulated capability to inhibit or reduce restenosis are being studied. This review presents recent results of experimental animal studies and first clinical trials of the presented method.

Słowa kluczowe

terapia fotodynamiczna PDT blaszka miażdżycowa restenoza angioplastyka wieńcowa

photodynamic teraphy PDT atheromatous plaque restenosis angioplastic treatment

Wydawca

Jacek Doskocz

Czasopismo

Acta Bio-Optica et Informatica Medica. Inżynieria Biomedyczna

Rocznik

2003

Tom

Vol. 9, nr 1-2

Strony

83--91

Opis fizyczny

Bibliogr. 54 poz.

Twórcy

autor

Derkacz A.

aderkacz@chirs.am.wroc.pl

Oddział Kardiodiagnostyki, Klinika Chirurgii Serca, Akademia Medyczna we Wrocławiu

autor

Biały D.

Oddział Kardiodiagnostyki, Klinika Chirurgii Serca, Akademia Medyczna we Wrocławiu

autor

Wawrzyńska M.

Oddział Kardiodiagnostyki, Klinika Chirurgii Serca, Akademia Medyczna we Wrocławiu

Bibliografia

1. T. Dougherty: Photosensitizers: therapy and detection of malignant tumours. Photochem. Photobioł., 45 (1987) 879-889.
2. A. Graczyk (red.): Fotodynamiczna metoda rozpoznawania i leczenia nowotworów. Dom Wydaw¬niczy Bellona, Warszawa 1999.
3. J. Levy: Photodynamic therapy. Trends. Biotechnol, 13 (1995) 14-18.
4. S.G. Rockson, P. Kramer, M. Razavi, et al.: Photo- angioplasty for human peripheral atherosclerosis: results of a phase 1 trial of photodynamic therapy with motexafin lutetium. Cirćulation, 102 (2000) 2322-2324.
5. A. Derkacz, D. Biały M. Protasiewicz, E. Pawlik, K. Abramski, A. Grobelny, Z. Pałasz: Opracowanie nowego dyfuzora promieniowania laserowego i jego zastosowanie w medycynie Acta Bio-Opt. Inf. Med., 8 (2002) 45^48.
6. J. Spears, J. Serur, D. Shropshire, et al.: Fluorescence of experimental atheromatous plaąues with hemathoporphyrin derivative. J. Clin. Invest., 71 (1983) 395-399.
7. Y. N. Hsiang, M.T. Crespo, L.S. Machan, et al.: Photodynamic therapy for atherosclerotic stenoses in Yucatan minis wine. Can. J. Surg., 37 (1994) 148-152.
8. G.M. Vincent, R.W. Mackie, E. Orme, et al.: In vivo photosensitizer-enhanced laser angioplasty in atherosclerotic Yucatan Miniswine. J. Clin. Med. Surg., 8 (1990) 59-61.
9. P. Dartsch, T. Ischinger, E. Betz: Responses of cultured smooth muscle cells from human non atherosclerotic arteries and primary stenosing lesions after photo radiation: implication for photodynamic therapy of vascular stenosis. J. Am. Coli. Cardiol., 7 (1990) 1545-1550.
10. G. Vincent: Photodynamic therapy of atherosclerosis and restenosis: a potentially exciting new treatment method. Proc. SP1E 2130 (1994) 2-10.
11. J. Kennedy, S. Marcus, R. Pottir: Photodynamic therapy (PDT) and photo diagnosis (PDD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J. Clin. Laser. Med. Surg., 14 (1996) 1545-1550.
12. M.P. Jenkins, G. Buonaccorosi, R. Mansfield, et al.: Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid. Cardiovasc. Res.,45 (2000) 478-485.
13. M. Herman, J. Webber, D. Fromm: Haemodynamic effects of 5-aminolewulinic acid in humans. J. Photochem. Photobioł. B., 43 (1998) 61-65.
14. G. LaMuraglia, P. Ortu, T. Flotte, et al.: Chloroaluminium sulfonatedphtalocyanine partitioning in normal and intimal hyperplastic artery in the rat: implications for photodynamic therapy. Am. J. PathoL, 142 (1993) 1898-1905.
15. J. Hayashi, Y. Kuroiwa, H. Sato, et al.: Trans- adventitial localization of atheromatous plaques by fluorescence emission spectrum analysis of mono- -L-aspartyl chlorin e6. Card. Res., 27 (1993) 1943-1947.
16. H. Narciso, S. Anderson, S. DeHoratius, et al.: SnET2 for the treatment of vascular disease: dose/response study in NZW rabbits. Proc SPIE 2395 (1995 ) 409-417.
17. S.W. Young, K.W. Woodbum, M. Wright, et al.: Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem. Photo- biol., 63 (1996) 892-897.
18. A. Yamaguchi, K.W. Woodboum, M. Hayase, et al.: Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model. Cirćulation, 102 (2000) 275-280.
19. A. Yamaguchi, K.W. Woodboum, M. Hayase, et al.: Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease. Transplantation, 71 (2001) 1526-1532.
20. P. Gonschior, A. Erdemnci, F. Gerheuser, et al.: Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemie administration. Abstract. Medline.
21. B.A. Allison, M.T. Crespo, A.K. Jain, et al.: Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyper lipidemic rabbits and balloon-inju- red New Zealand rabbits. Photochem. Photobioł., 65 (1997) 877-883.
22. H.E. de Vries, A.C. Moor, T.M. Dubbelman, et al.: Oxidized low-density lipoprotein as a delivery system for photo sens itizers: implications for photodynamic therapy of atherosclerosis. J. Pharmacol. Exp. Ther., 289 (1999) 528-534
23. M.R. Hamblin, J.L. Miller, B. Ortel: Scavenger- -receptor targeted photodynamic therapy. Photo- chem. Photobiol., 72 (2000) 533-540.
24. Z. Chen, K.W. Woodbum, C. Shi, et al.: Photodynamic therapy with motexafm lutetium induces redox-sensitive apoptosis of vascular cells. Atherioscler. Thromb. Vasc. Biot, 21 (2001) 759-764.
25. P.C. Dartsch, K. Wunderlich, E. Ben-Hur: Aluminium phtalocyanines-induced photolysis of human vascular wail cells in culture and the of fluor ide on photodynamic action. Coron. Artery Dis., 5 (1994) 851-855.
26. F. Adili, T. Scholtz, M. Hille, et al.: Photodynamic therapy mediated induction of accelerated re-endo- the lialisation following injury to the arterial wali: implications for the prevention of restenosis. Eur. J. Vasc. Endovasc. Surg., 24 (2002) 166-175.
27. J. Heckenkamp, D. Leszczyński, J. Schiereck, et al.: Different effects of photodynamic therapy and gamma-irradiation on vascular muscle cells and matrix: implications for inhibiting restenosis. Atherioscler. Thromb. Vasc. Biot, 19 (1999) 2154-2161.
28. D.J. Granville, B.A. Casidy, D.O. Ruehlmann, et al.: Mitochondrial release of apoptosis-inducing factor and cytochrome c during smooth muscle cell apoptosis. Am. J. Pathol., 159 (2001) 305-311.
29. R.G. Statius van Eps, L.L. Mark, J. Schiereck , et al.: Photodynamic therapy inhibits the injury-induced fibrotic response of vascular smooth cells. Eur. J. Vasc. Endovasc. Surg., 18 (1999) 417—423.
30. P.R. Waterman, M. Overhaus, J. Heckenkamp, et al.: Mechanisms of reduced human vascular cell migration after photodynamic therapy. Photochem. Photobiol., 75 (2002) 46-50.
31. M. Overhaus, J. Heckenkamp, S. Kossodo, et al.: Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ. Res., 86 (2000) 334-340.
32. G.M. LaMuraglia, J. Schiereck, J. Heckenkamp, et al.: Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. Am. J. Pathol., 157 (2000) 867-875.
33. T. Katoh, T. Asahara, Y. Naitoh, et al.: In vivo intravascular laser photodynamic therapy in rabbit atherosclerotic lesions using a lateral direction fibre. Lasers. Surg. Med., 20 (1997) 373-381.
34. T. Saito, J. Hayashi, H. Sato, et al.: Scanning electron microscopic analysis for acute photodynamic therapy for atherosclerotic plaques of rabbit aorta by using pheophorbide derivative. J. Clin. Med. Surg., 14(1996) 1-6.
35. Y.N. Hsiang, M.T. Crespo, L.S. Machan, et al.: Photodynamic therapy for atherosclerotic stenoses in Yucatan mini swine. Can. J. Surg., 37 (1994) 148-152.
36. G.M. Vincent, R.W. Mackie, E. Orme, et al.: In vivo photosensitizer enhanced laser angioplasty in atherosclerotic Yucatan mini swine. J. Clin. Laser. Med. Surg., 8 (1990) 59-61.
37. T. Ameima, H. Nakalima, T. Katoh, et al.: Photodynamic therapy of atherosclerosis using YAG-OPO laser and Porflmer sodium, and comparison with using argon-dye laser. Jpn Circ. J., 63 (1999) 288-295.
38. R.W. Mackie, G.M. Vincent, J. Fox, et al.: In-vivo canine coronary artery laser irradiation: photodynamic therapy using Di hematoporphyrin ether and 630 nm laser. Lasers. Surg. Med., 11 (1991) 535-544.
39. Y.N. Hsiang, M.E. Todd, R.D. Bower: Determining light dose for photodynamic therapy of atherosclerotic lesions in the Yucatan mini swine. J. Endovasc. Surg., 2 (1995) 365-371.
40. K.W. Woodbum, Q. Fan, D. Kessel, et al.: Phototherapy of cancer and atheromatous plaąue with texapiryns. J. Cin. Laser. Med. Surg., 14 (1996)343-348.
41. J. Hayashi, T. Saito, K. Aizawa: Change in Chemical composition of lipids accumulated in atheroma’s of rabbits following photodynamic therapy. Lasers Surg. Med., 21 (1997) 287-293.
42. T. Nagae, A.Y. Luie, K. Aizawa, et al.: Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein - chlorin e6 conjugates. J. Cardiovasc. Surg., 39 (1998) 709-715.
43. A. Visona, A. Angelini, S. Gobbo, et al.: Local photodynamic therapy with Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia. J. Photochem. Photobiol .B., 57 (2000) 94-101
44. J. Heckenkamp, F. Adili, J. Kishimoto, et al.: Local photodynamic action of methylene blue favourably modulates the postinterventional vascular wound healing response. J. Vasc. Surg., 31 (2000) 1168-1177.
45. M.P. Jenkins, G. Buonaccorosi, A. MacRobert, et al.: Intra-arterial photodynamic therapy using 5-ALA in swine model. Eur. J. Endovasc. Surg., 16 (1998)284-281.
46. M. Usui, T. Asahara, Y. Naitoh, et al.: Photodynamic therapy for prevention of intimal hyper- plasi-a in balloon-injured rabbit arteries. Jpn. Circ. J.,63 (1999) 387-393.
47. E. Adili, R.G. Statius van Eps, T.J. Flotte, et al.: Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia. Lasers. Surg. Med., 23 (1998) 263-273.
48. T. Nagae, K. Aizawa, N. Uchimura, et al.: Endovascular photodynamic therapy using mono-L- -aspartyl-chlorin e6 to inhibit intimal hyperplasia in balloon injured rabbit arteries. Lasers Surg. Med., 28 (2001) 381-388.
49. E.E. Gabeler, R. van Hillegersberg, R.G. Statius van Eps, et al.: Endovascular photodynamic therapy with aminolaevulinic acid prevents induced intimal hyperplasia and constrictive remodelling. Eur. J. Vasc. Endovasc. Surg., 24 (2002) 322-331.
50. M.P. Jenkins, G. Buonaccorosi, R. Mansfield, et al.: Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid. Cardiovasc. Res., 45 (2000) 478^185.
51. G. Valassis, I. Pragst, C. Adolfs, et al.: Local photodynamic therapy reduces tissue hyperplasia after stenting in an experimental restenosis model. Basic Res. Cardiol., 97 (2002) 132-136.
52. R.G. Statius van Eps, N.R. ChandraSekar, T. Hassan, et al.: Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia. Photochem. Photo- biol., 67 (1998) 337-342.
53. M.P. Jenkins, G.R. Buonaccorosi, M. Raphael, et al.: Glinieal study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br. J. Surg., 86 (1999) 1258-1263.
54. S.G. Rockson, D.P. Lorentz, W.F. Cheong, et al.: Photo angioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation, 102 (2000) 591-596

Typ dokumentu

Bibliografia

Identyfikator YADDA

bwmeta1.element.baztech-article-BSL8-0021-0017